Indiana

Back to map

Showing 1-10 of 14 grants

Title Institution Researcher Program Duration Total Award Amount
Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: multicenter, registry-based study Trustees of Indiana University Viral Shah Improving Lives 01-September-2025 to 31-August-2028 $1.603.777,39
SOLUBLE LYMPHOCYTE ACTIVATION GENE-3 (s-LAG-3): A POTENTIAL SURROGATE MARKER FOR TYPE-1 DIABETES PROGRESSION AND IMMUNOTHERAPY SUCCESS Trustees of Indiana University Jon Piganelli Cures 01-July-2025 to 30-June-2026 $153.000,00
Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D Indiana Biosciences Research Institute Michael Kalwat Cures 01-December-2024 to 30-November-2027 $748.169,00
Relationship of Time-In-Range with microvascular complications in type 1 diabetes Trustees of Indiana University Viral Shah Improving Lives 01-February-2024 to 31-July-2025 $71.123,95
CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes Trustees of Indiana University Viral Shah Cures 01-November-2024 to 31-October-2027 $900.000,00
Investigating Combinatorial Use of Inhibitors of Focal Adhesion Kinase and PFKFB3 for Reversal of Type 1 Diabetes Trustees of Indiana University Jon Piganelli Cures 01-August-2023 to 30-June-2025 $334.595,29
Defining the role of islet-derived extracellular vesicle PD-L1 cargo in type-1 diabetes Trustees of Indiana University Chaitra Rao Cures 01-March-2024 to 30-April-2027 $228.537,45
Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes Trustees of Indiana University Amelia Linnemann Cures 01-October-2023 to 30-September-2025 $560.000,00
Targeting ER cargo proteins for beta cell protection against cellular stress and autoimmunity Indiana Biosciences Research Institute Erica Cai Cures 01-September-2023 to 31-August-2026 $499.934,12
Genome-scale CRISPR screens identify ER export cargo proteins as mediators for β-cell stress response and antigen presentation Indiana Biosciences Research Institute Isabela Lovizutto Iessi Longo Cures 01-March-2023 to 28-February-2026 $135.307,11